These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8050412)

  • 1. Old protocols, as do old habits, die hard.
    Zeiger E
    Environ Mol Mutagen; 1994; 24(1):1-2. PubMed ID: 8050412
    [No Abstract]   [Full Text] [Related]  

  • 2. Recommendations for the mutagenicity testing of new pharmaceuticals.
    Schöneich J; Srám RJ; Bogajewski J
    Pol J Pharmacol Pharm; 1982; 34(4):201-5. PubMed ID: 7182840
    [No Abstract]   [Full Text] [Related]  

  • 3. [Test for the mutagenicity of fish filet exposed to gamma-irradiation].
    Osipova IN; Zaĭtsev AN
    Radiobiologiia; 1981; 21(4):603-6. PubMed ID: 7302168
    [No Abstract]   [Full Text] [Related]  

  • 4. [Complex trial of the genetic activity of the hexavalent chromium ion in vitro and in vivo].
    Pashin IuV; Kozachenko VI; Zatsepilova TA; Soboleva LS
    Tsitol Genet; 1981; 15(5):66-9. PubMed ID: 7303153
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of alternative distributions of postimplantation death in the dominant lethal assay.
    Smith DM; James DA
    Mutat Res; 1984 Sep; 128(2):195-206. PubMed ID: 6472312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A guide for mutagenicity testing using the dominant lethal assay.
    Green S; Lavappa KS; Manandhar M; Sheu CJ; Whorton E; Springer JA
    Mutat Res; 1987 Oct; 189(2):167-74. PubMed ID: 3657832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rodent dominant lethal assay: a proposed format for data presentation that alerts to pseudo-dominant lethal effects.
    Ashby J; Clapp MJ
    Mutat Res; 1995 Aug; 330(1-2):209-18. PubMed ID: 7623866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of in vivo mammalian testing systems.
    Oleson FB
    Prog Clin Biol Res; 1990; 340B():171-84. PubMed ID: 2203004
    [No Abstract]   [Full Text] [Related]  

  • 9. Mutagenesis assays with whole mammals.
    Russell LB; Elias P; Matter BE; Sullivan F
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):245-76. PubMed ID: 6935182
    [No Abstract]   [Full Text] [Related]  

  • 10. [The Soviet antimalarial preparation dabequine studied for the presence of mutagenic activity].
    Frol'tsova AE; Astaf'eva IP; Lebedeva MN; Lychko ND
    Med Parazitol (Mosk); 1984; (4):16-21. PubMed ID: 6384756
    [No Abstract]   [Full Text] [Related]  

  • 11. Current status of bioassays in genetic toxicology--the dominant lethal assay. A report of the U.S. Environmental Protection Agency Gene-Tox Program.
    Green S; Auletta A; Fabricant J; Kapp R; Manandhar M; Sheu CJ; Springer J; Whitfield B
    Mutat Res; 1985 Jul; 154(1):49-67. PubMed ID: 3889623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of results from a collaborative study of the dominant lethal assay.
    James DA; Smith DM
    Mutat Res; 1982 Aug; 97(4):303-14. PubMed ID: 7121502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenicity and dominant lethal test of kojic acid--Ames test, forward mutation test in cultured Chinese hamster cells and dominant lethal test in mice.
    Shibuya T; Murota T; Sakamoto K; Iwahara S; Ikeno M
    J Toxicol Sci; 1982 Nov; 7(4):255-62. PubMed ID: 7169638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The assay of 4-chloromethylbiphenyl in the dominant lethal assay in mice.
    Wickramaratne GA; Richards D; Kilmartin M; Keetch D
    Mutat Res; 1982; 100(1-4):351-2. PubMed ID: 7057770
    [No Abstract]   [Full Text] [Related]  

  • 15. Tests for induction of dominant-lethal mutations and heritable translocations with tetrahydrocannabinol in male mice.
    Generoso WM; Cain KT; Cornett CV; Shelby MD
    Mutat Res; 1985; 143(1-2):51-3. PubMed ID: 2987686
    [No Abstract]   [Full Text] [Related]  

  • 16. [Determination of the mutagenic potential of an environmental pollutant, mercuric chloride].
    Vasil'eva IM; Sdirkova NI; Zasukhina GD; Butenko PG; Krasovskiĭ GN
    Tsitol Genet; 1982; 16(2):21-4. PubMed ID: 6285566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of dominant lethal and heritable translocation methodologies.
    Anderson D; Hodge MC; Palmer S; Purchase IF
    Mutat Res; 1981 Dec; 85(6):417-29. PubMed ID: 7339488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between early deaths and implants in control and mutagen-treated CD-1 mice in dominant lethal assays.
    Anderson D; McGregor DB; Weight TM
    Mutat Res; 1981 Apr; 81(2):187-96. PubMed ID: 7195460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of prolonged chemical treatment with cyclophosphamide and 6-mercaptopurine in the dominant lethal test system.
    Moreland FM; Sheu CW; Springer JA; Green S
    Mutat Res; 1981 Oct; 90(2):193-9. PubMed ID: 7199118
    [No Abstract]   [Full Text] [Related]  

  • 20. Investigation of hyperthermia-induced dominant lethal mutations in male mice.
    Garriott ML; Chrisman CL
    J Hered; 1981; 72(5):338-42. PubMed ID: 7328303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.